{"id":234241,"date":"2023-07-21T07:07:51","date_gmt":"2023-07-21T07:07:51","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=234241"},"modified":"2023-07-21T07:07:51","modified_gmt":"2023-07-21T07:07:51","slug":"dopa-decarboxylase-inhibitors","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopa-decarboxylase-inhibitors\/","title":{"rendered":"Dopa-decarboxylase inhibitors"},"content":{"rendered":"<div class=\"group w-full text-gray-800 dark:text-gray-100 border-b border-black\/10 dark:border-gray-900\/50 bg-gray-50 dark:bg-[#444654] sm:AIPRM__conversation__response\">\n<div class=\"flex p-4 gap-4 text-base md:gap-6 md:max-w-2xl lg:max-w-[38rem] xl:max-w-3xl md:py-6 lg:px-0 m-auto\">\n<div class=\"relative flex w-[calc(100%-50px)] flex-col gap-1 md:gap-3 lg:w-[calc(100%-115px)]\">\n<div class=\"flex flex-grow flex-col gap-3\">\n<div class=\"min-h-[20px] flex items-start overflow-x-auto whitespace-pre-wrap break-words flex-col gap-4\">\n<div class=\"markdown prose w-full break-words dark:prose-invert light AIPRM__conversation__response\">\n<p>Medications employed in managing the movement disorder known as Parkinson&#8217;s disease. The two main dopa-decarboxylase inhibitors, co-beneldopa and co-careldopa, are combinations of levodopa with benserazide and levodopa with carbidopa, respectively. These drugs prevent the activation of levodopa except within the brain, thereby reducing the occurrence of common side effects like nausea and vomiting.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Medications employed in managing the movement disorder known as Parkinson&#8217;s disease. The two main dopa-decarboxylase inhibitors, co-beneldopa and co-careldopa, are combinations of levodopa with benserazide and levodopa with carbidopa, respectively. These drugs prevent the activation of levodopa except within the brain, thereby reducing the occurrence of common side effects like nausea and vomiting. &nbsp;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-234241","post","type-post","status-publish","format-standard","hentry","category-d"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dopa-decarboxylase inhibitors - Definition of Dopa-decarboxylase inhibitors<\/title>\n<meta name=\"description\" content=\"Medications employed in managing the movement disorder known as Parkinson&#039;s disease. The two main dopa-decarboxylase inhibitors, co-beneldopa and co-careldopa, are combinations of levodopa with benserazide and levodopa with carbidopa, respectively. These drugs prevent the activation of levodopa except within the brain, thereby reducing the occurrence of common side effects like nausea and vomiting.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopa-decarboxylase-inhibitors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dopa-decarboxylase inhibitors - Definition of Dopa-decarboxylase inhibitors\" \/>\n<meta property=\"og:description\" content=\"Medications employed in managing the movement disorder known as Parkinson&#039;s disease. The two main dopa-decarboxylase inhibitors, co-beneldopa and co-careldopa, are combinations of levodopa with benserazide and levodopa with carbidopa, respectively. These drugs prevent the activation of levodopa except within the brain, thereby reducing the occurrence of common side effects like nausea and vomiting.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopa-decarboxylase-inhibitors\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-21T07:07:51+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopa-decarboxylase-inhibitors\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopa-decarboxylase-inhibitors\/\",\"name\":\"Dopa-decarboxylase inhibitors - Definition of Dopa-decarboxylase inhibitors\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2023-07-21T07:07:51+00:00\",\"dateModified\":\"2023-07-21T07:07:51+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Medications employed in managing the movement disorder known as Parkinson's disease. The two main dopa-decarboxylase inhibitors, co-beneldopa and co-careldopa, are combinations of levodopa with benserazide and levodopa with carbidopa, respectively. These drugs prevent the activation of levodopa except within the brain, thereby reducing the occurrence of common side effects like nausea and vomiting.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopa-decarboxylase-inhibitors\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopa-decarboxylase-inhibitors\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/dopa-decarboxylase-inhibitors\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dopa-decarboxylase inhibitors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dopa-decarboxylase inhibitors - Definition of Dopa-decarboxylase inhibitors","description":"Medications employed in managing the movement disorder known as Parkinson's disease. The two main dopa-decarboxylase inhibitors, co-beneldopa and co-careldopa, are combinations of levodopa with benserazide and levodopa with carbidopa, respectively. These drugs prevent the activation of levodopa except within the brain, thereby reducing the occurrence of common side effects like nausea and vomiting.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopa-decarboxylase-inhibitors\/","og_locale":"en_US","og_type":"article","og_title":"Dopa-decarboxylase inhibitors - Definition of Dopa-decarboxylase inhibitors","og_description":"Medications employed in managing the movement disorder known as Parkinson's disease. The two main dopa-decarboxylase inhibitors, co-beneldopa and co-careldopa, are combinations of levodopa with benserazide and levodopa with carbidopa, respectively. These drugs prevent the activation of levodopa except within the brain, thereby reducing the occurrence of common side effects like nausea and vomiting.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopa-decarboxylase-inhibitors\/","og_site_name":"Glossary","article_published_time":"2023-07-21T07:07:51+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopa-decarboxylase-inhibitors\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopa-decarboxylase-inhibitors\/","name":"Dopa-decarboxylase inhibitors - Definition of Dopa-decarboxylase inhibitors","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2023-07-21T07:07:51+00:00","dateModified":"2023-07-21T07:07:51+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Medications employed in managing the movement disorder known as Parkinson's disease. The two main dopa-decarboxylase inhibitors, co-beneldopa and co-careldopa, are combinations of levodopa with benserazide and levodopa with carbidopa, respectively. These drugs prevent the activation of levodopa except within the brain, thereby reducing the occurrence of common side effects like nausea and vomiting.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopa-decarboxylase-inhibitors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/dopa-decarboxylase-inhibitors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/dopa-decarboxylase-inhibitors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Dopa-decarboxylase inhibitors"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/234241","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=234241"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/234241\/revisions"}],"predecessor-version":[{"id":234242,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/234241\/revisions\/234242"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=234241"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=234241"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=234241"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}